Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series
Annals of Oncology, 06/01/09
Grosso F et al. - The data indicate that the high response rate of MLS to trabectedin translates into prolonged PFS. Surgery of residual metastatic disease is already used quite extensively in metastatic MLS. Trabectedin may give further significance to this kind of surgery.
Related Articles
Fine-needle aspiration in myxofibrosarcoma: Experience of Institut Curie
Diagnostic Cytopathology, 11/11/09
Relevance Score: 67%
Fine-needle aspiration cytology of extraskeletal myxoid chondrosarcoma: A case report
Diagnostic Cytopathology, 11/11/09
Relevance Score: 43%
Atypical lipomatous tumor/well-differentiated liposarcoma of the parotid gland: Case report and literature review
ENT Journal, 10/16/09
Relevance Score: 43%
Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma
Modern Pathology, 10/13/09
Relevance Score: 43%
Primary cutaneous myxoid spindle cell squamous cell carcinoma: a clinicopathologic study and review of the literature
Journal of Cutaneous Pathology, 10/09/09
Relevance Score: 42%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: A phase II study
International Journal of Cancer, 12/18/09
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: Results from a randomized phase II study
Palliative Medicine, 12/18/09
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: An Eastern Cooperative Oncology Group Trial
Breast Cancer Research and Treatment, 12/17/09
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases
Human Pathology, 12/17/09
Aggressive fibromatosis in children and adolescents
Cancer, 12/15/09
Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases
Annals of Diagnostic Pathology, 12/12/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


